Cargando…
Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
For more than five decades, the field of Alzheimer's disease (AD) has focused on two main hypotheses positing amyloid-beta (Aβ) and Tau phosphorylation (pTau) as key pathogenic mediators. In line with these canonical hypotheses, several groups around the world have shown that the synaptotoxicit...
Autores principales: | Mondragón-Rodríguez, Siddhartha, Salgado-Burgos, Humberto, Peña-Ortega, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481966/ https://www.ncbi.nlm.nih.gov/pubmed/32952546 http://dx.doi.org/10.1155/2020/2960343 |
Ejemplares similares
-
Cortical Circuitry and Synaptic Dysfunctions in Alzheimer's Disease and Other Dementias
por: Ranieri, Federico, et al.
Publicado: (2021) -
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Wu, Moxin, et al.
Publicado: (2021) -
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
por: Kametani, Fuyuki, et al.
Publicado: (2018) -
Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2013) -
Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)